国家药监局近日在其官方网站上发布通告，称在2023年国家化妆品抽样检验工作中，经四川省药品检验研究院等单位检验，产品标签标示委托方为广州市康采医疗用品有限公司、受托方为广州美淳化妆品有限公司生产的好脸面祛痘维肤膏等6批次化妆品不符合规定。对此，国家药监局表示将依法立案调查。
中文翻译：
National Medical Products Administration recently announced that in the national cosmetics sampling inspection work in 2023, the inspection units including Sichuan Provincial Drug Inspection Research Institute found that 6 batches of cosmetics produced by Guangzhou Kangcai Medical Supplies Co., Ltd., with the labeled entrustment party as Guangzhou Meichun Cosmetics Co., Ltd., did not comply with the regulations. The National Medical Products Administration stated that it will investigate the matter legally.
关键词：化妆品，禁用原料，调查
新闻内容：
化妆品安全问题再次引发关注。国家药监局透露，在2023年的化妆品抽检中，6批次化妆品被检出含有禁用原料。这些化妆品由广州市康采医疗用品有限公司委托广州美淳化妆品有限公司生产，其中包括好脸面祛痘维肤膏等产品。针对此事，国家药监局已依法立案调查。
中文翻译：
The safety of cosmetics has again become the focus of attention. The National Medical Products Administration revealed that in the cosmetics sampling inspection in 2023, 6 batches of cosmetics were found to contain prohibited ingredients. These cosmetics were produced by Guangzhou Kangcai Medical Supplies Co., Ltd. entrusted with Guangzhou Meichun Cosmetics Co., Ltd., including products such as Haolianmian Acne Vulgaris Cream. In response to this, the National Medical Products Administration has launched a legal investigation.
关键词：化妆品，禁用原料，调查
新闻内容：
国家药监局近日发布通告，指出6批次化妆品在2023年的抽检中不符规定，原因在于含有禁用原料。涉及产品包括广州市康采医疗用品有限公司委托广州美淳化妆品有限公司生产的好脸面祛痘维肤膏等。为确保消费者权益，国家药监局已依法对这些化妆品进行立案调查。
中文翻译：
The National Medical Products Administration recently announced that 6 batches of cosmetics did not comply with the regulations in the 2023 inspection, due to the presence of prohibited ingredients. The involved products include Haolianmian Acne Vulgaris Cream, produced by Guangzhou Kangcai Medical Supplies Co., Ltd. under the entrustment of Guangzhou Meichun Cosmetics Co., Ltd. To protect consumer rights and interests, the National Medical Products Administration has launched a legal investigation into these cosmetics.
【来源】http://www.chinanews.com/gn/2024/01-08/10142310.shtml
Views: 1